The Impact of Covid-19 on the Pharmaceutical Industry, a Chemanager Featured Story
Being in the public eye, the pharmaceutical industry has responded extremely well to the coronavirus pandemic. However, the Corona crisis has uncovered some issues that are smoldering under the surface and need to be addressed by the industry and by politics alike.
For instance, the pandemic puts pharmaceutical research and development strategies to the test and challenges manufacturing planning and supply chain management. Andrew Badrot, CEO of C2 Pharma, a Luxembourg-based manufacturer, and distributor of active pharmaceutical ingredients (APls), is a senior pharma expert and a close observer of industry trends. For CHEManager, he analyzes the current situation and how this pandemic may kick of changes in the pharma market.
Click here to view the article.